{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:23:31Z","timestamp":1789140211783,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1124\/jpet.124.002138","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T17:20:30Z","timestamp":1726507230000},"page":"100021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of pyrimidine structure-based compounds as allosteric ligands of the dopamine transporter as therapeutic agents for NeuroHIV"],"prefix":"10.1016","volume":"392","author":[{"given":"Ana Catya","family":"Jimenez-Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamison A.","family":"Hastie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0289-125X","authenticated-orcid":false,"given":"Sarah E.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine D.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Moukha-Chafiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sixue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa H.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subramaniam","family":"Ananthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne E.","family":"Augelli-Szafran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.124.002138_bib1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s13365-018-0691-8","article-title":"Astrocytes as an HIV CNS reservoir: highlights and reflections of an NIMH-sponsored symposium","volume":"24","author":"Al-Harti","year":"2018","journal-title":"J\u00a0Neurovirol"},{"issue":"9.20","key":"10.1124\/jpet.124.002138_bib2","first-page":"1","article-title":"Overview of critical parameters for the design and execution of a high-throughput screen for allosteric ligands","volume":"74","author":"Alt","year":"2016","journal-title":"Curr Protoc Pharmacol"},{"key":"10.1124\/jpet.124.002138_bib3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s13365-012-0144-8","article-title":"Detection of anti-tat antibodies in CSF of individuals with HIV-associated neurocognitive disorders","volume":"19","author":"Bachani","year":"2013","journal-title":"J\u00a0Neurovirol"},{"key":"10.1124\/jpet.124.002138_bib4","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00002030-199606000-00002","article-title":"Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry","volume":"10","author":"Bagasra","year":"1996","journal-title":"AIDS"},{"key":"10.1124\/jpet.124.002138_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00002030-199401000-00010","article-title":"Cerebrospinal fluid dopamine in HIV-1 infection","volume":"8","author":"Berger","year":"1994","journal-title":"AIDS"},{"key":"10.1124\/jpet.124.002138_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002030-199901140-00003","article-title":"Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis","volume":"13","author":"Brack-Werner","year":"1999","journal-title":"AIDS"},{"key":"10.1124\/jpet.124.002138_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12758-w","article-title":"HIV-infected macrophages and microglia that survive acute infection become viral reservoirs by a mechanism involving Bim","volume":"7","author":"Castellano","year":"2017","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.124.002138_bib8","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2165\/00003495-200666060-00004","article-title":"Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy","volume":"66","author":"Chander","year":"2006","journal-title":"Drugs"},{"key":"10.1124\/jpet.124.002138_bib9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/QAD.0000000000002076","article-title":"HIV brain latency as measured by CSF BcL11b relates to disrupted brain cellular energy in virally suppressed HIV infection","volume":"33","author":"Cysique","year":"2019","journal-title":"AIDS"},{"key":"10.1124\/jpet.124.002138_bib10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1124\/jpet.122.001291","article-title":"Novel allosteric modulator Southern Research Institute-32743 reverses HIV-1 transactivator of transcription-induced increase in dopamine release in the caudate putamen of inducible transactivator of transcription transgenic mice","volume":"384","author":"Davis","year":"2023","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1124\/jpet.124.002138_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235407","article-title":"Enhancement of fast scan cyclic voltammetry detection of dopamine with tryptophan-modified electrodes","volume":"15","author":"Davis","year":"2020","journal-title":"PLoS One"},{"key":"10.1124\/jpet.124.002138_bib12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/13550280009015824","article-title":"Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy","volume":"6","author":"Del Valle","year":"2000","journal-title":"J\u00a0Neurovirol"},{"key":"10.1124\/jpet.124.002138_bib13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00002826-200007000-00004","article-title":"Decreased homovanilic acid in cerebrospinal fluid correlates with impaired neuropsychologic function in HIV-1-infected patients","volume":"23","author":"di Rocco","year":"2000","journal-title":"Clin Neuropharmacol"},{"key":"10.1124\/jpet.124.002138_bib14","first-page":"1715","article-title":"HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment","volume":"264","author":"Eggers","year":"2017","journal-title":"J\u00a0Neurol"},{"key":"10.1124\/jpet.124.002138_bib15","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0092-8674(88)90263-2","article-title":"Cellular uptake of the tat protein from human immunodeficiency virus","volume":"55","author":"Frankel","year":"1988","journal-title":"Cell"},{"key":"10.1124\/jpet.124.002138_bib16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3389\/fneur.2019.00285","article-title":"Release of soluble insulin receptor from neurons by cerebrospinal fluid from patients with neurocognitive dysfunction and HIV infection","volume":"10","author":"Gerena","year":"2019","journal-title":"Front Neurol"},{"issue":"Suppl 2","key":"10.1124\/jpet.124.002138_bib17","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1097\/QAD.0000000000002268","article-title":"Presence of Tat and transactivation response element in spinal fluid despite antiretroviral therapy","volume":"33","author":"Henderson","year":"2019","journal-title":"AIDS"},{"key":"10.1124\/jpet.124.002138_bib18","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00702-013-1086-x","article-title":"Increases in CSF dopamine in HIV patients are due to the dopamine transporter 10\/10-repeat allele which is more frequent in HIV-infected individuals","volume":"120","author":"Horn","year":"2013","journal-title":"J\u00a0Neural Transm (Vienna)"},{"key":"10.1124\/jpet.124.002138_bib19","doi-asserted-by":"crossref","first-page":"13588","DOI":"10.1073\/pnas.1308673110","article-title":"Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein","volume":"110","author":"Johnson","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/jpet.124.002138_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/QAD.0000000000003379","article-title":"The global burden of cognitive impairment in people with HIV","volume":"37","author":"Keng","year":"2023","journal-title":"AIDS"},{"key":"10.1124\/jpet.124.002138_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neuropharm.2016.06.011","article-title":"The effects of HIV-1 regulatory TAT protein expression on brain reward function, response to psychostimulants and delay-dependent memory in mice","volume":"109","author":"Kesby","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.124.002138_bib22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/13550280902973952","article-title":"Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains","volume":"15","author":"Kumar","year":"2009","journal-title":"J\u00a0Neurovirol"},{"key":"10.1124\/jpet.124.002138_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s13365-010-0003-4","article-title":"Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance","volume":"17","author":"Kumar","year":"2011","journal-title":"J\u00a0Neurovirol"},{"key":"10.1124\/jpet.124.002138_bib24","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/jnr.490280313","article-title":"Cerebrospinal fluid catecholamine metabolites in HIV-infected patients","volume":"28","author":"Larsson","year":"1991","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1124\/jpet.124.002138_bib25","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/QAD.0000000000002512","article-title":"Productive HIV infection in astrocytes can be established via a nonclassical mechanism","volume":"34","author":"Li","year":"2020","journal-title":"AIDS"},{"key":"10.1124\/jpet.124.002138_bib26","doi-asserted-by":"crossref","first-page":"12190","DOI":"10.1523\/JNEUROSCI.3019-08.2008","article-title":"NMDA receptor activation by HIV-Tat protein is clade dependent","volume":"28","author":"Li","year":"2008","journal-title":"J\u00a0Neurosci"},{"key":"10.1124\/jpet.124.002138_bib27","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/82199","article-title":"Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands","volume":"6","author":"Liu","year":"2000","journal-title":"Nat Med"},{"key":"10.1124\/jpet.124.002138_bib28","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1046\/j.1471-4159.2002.01212.x","article-title":"Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function","volume":"83","author":"Maragos","year":"2002","journal-title":"J\u00a0Neurochem"},{"key":"10.1124\/jpet.124.002138_bib29","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3389\/fnagi.2020.00168","article-title":"Extracellular HIV-1 Tat mediates increased glutamate in the CNS leading to onset of senescence and progression of HAND","volume":"12","author":"Marino","year":"2020","journal-title":"Front Aging Neurosci"},{"key":"10.1124\/jpet.124.002138_bib30","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/QAD.0b013e32832c4152","article-title":"Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance","volume":"23","author":"Marra","year":"2009","journal-title":"AIDS"},{"key":"10.1124\/jpet.124.002138_bib31","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s11481-013-9464-6","article-title":"Mutation of tyrosine 470 of human dopamine transporter is critical for HIV-1 Tat-induced inhibition of dopamine transport and transporter conformational transitions","volume":"8","author":"Midde","year":"2013","journal-title":"J\u00a0Neuroimmune Pharmacol"},{"key":"10.1124\/jpet.124.002138_bib32","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s11481-015-9583-3","article-title":"Mutations at tyrosine 88, lysine 92 and tyrosine 470 of human dopamine transporter result in an attenuation of HIV-1 Tat-induced inhibition of dopamine transport","volume":"10","author":"Midde","year":"2015","journal-title":"J\u00a0Neuroimmune Pharmacol"},{"key":"10.1124\/jpet.124.002138_bib33","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12883-020-01857-3","article-title":"HIV-associated neurocognitive disorders at Moi teaching and referral hospital, Eldoret, Kenya","volume":"20","author":"Mohamed","year":"2020","journal-title":"BMC Neurol"},{"key":"10.1124\/jpet.124.002138_bib34","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1128\/JVI.03333-13","article-title":"Epigenetic regulation of HIV-1 latency in astrocytes","volume":"88","author":"Narasipura","year":"2014","journal-title":"J\u00a0Virol"},{"key":"10.1124\/jpet.124.002138_bib35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1749-6632.2009.05277.x","article-title":"Human immunodeficiency virus-associated neurocognitive disorder: pathophysiology in relation to drug addiction","volume":"1187","author":"Nath","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/jpet.124.002138_bib36","first-page":"948","article-title":"Substantia nigra hyperechogenicity and CSF dopamine depletion in HIV","volume":"256","author":"Obermann","year":"2009","journal-title":"J\u00a0Neurol"},{"key":"10.1124\/jpet.124.002138_bib37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s13365-012-0147-5","article-title":"The Alzheimer\u2019s disease-8 and Montreal Cognitive Assessment as screening tools for neurocognitive impairment in HIV-infected persons","volume":"19","author":"Overton","year":"2013","journal-title":"J\u00a0Neurovirol"},{"key":"10.1124\/jpet.124.002138_bib38","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/npp.2013.201","article-title":"Effects of conditional central expression of HIV-1 tat protein to potentiate cocaine-mediated psychostimulation and reward among male mice","volume":"39","author":"Paris","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.124.002138_bib39","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1124\/jpet.108.139675","article-title":"Studies of the biogenic amine transporters. 12. Identification of novel partial inhibitors of amphetamine-induced dopamine release","volume":"326","author":"Pariser","year":"2008","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1124\/jpet.124.002138_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141340","article-title":"Characterization of fast-scan cyclic voltammetric electrodes using paraffin as an effective sealant with in\u00a0vitro and in\u00a0vivo applications","volume":"10","author":"Ramsson","year":"2015","journal-title":"PLoS One"},{"key":"10.1124\/jpet.124.002138_bib41","doi-asserted-by":"crossref","first-page":"11568","DOI":"10.1021\/ac402884n","article-title":"In situ electrode calibration strategy for voltammetric measurements in\u00a0vivo","volume":"85","author":"Roberts","year":"2013","journal-title":"Anal Chem"},{"key":"10.1124\/jpet.124.002138_bib42","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1124\/jpet.114.222299","article-title":"Studies of the biogenic amine transporters 15. Identification of novel allosteric dopamine transporter ligands with nanomolar potency","volume":"353","author":"Rothman","year":"2015","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1124\/jpet.124.002138_bib43","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1124\/jpet.108.149088","article-title":"Studies of the biogenic amine transporters. 13. Identification of \u201cagonist\u201d and \u201cantagonist\u201d allosteric modulators of amphetamine-induced dopamine release","volume":"329","author":"Rothman","year":"2009","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1124\/jpet.124.002138_bib44","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/00001756-199603220-00015","article-title":"Dopamine deficits in the brain: the neurochemical basis of parkinsonian symptoms in AIDS","volume":"7","author":"Sardar","year":"1996","journal-title":"Neuroreport"},{"key":"10.1124\/jpet.124.002138_bib45","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00702-010-0415-6","article-title":"Increased dopaminergic neurotransmission in therapy-naive asymptomatic HIV patients is not associated with adaptive changes at the dopaminergic synapses","volume":"117","author":"Scheller","year":"2010","journal-title":"J\u00a0Neural Transm (Vienna)"},{"key":"10.1124\/jpet.124.002138_bib46","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/QAD.0b013e3283354a7b","article-title":"Cognitive dysfunction in HIV patients despite long-standing suppression of viremia","volume":"24","author":"Simioni","year":"2010","journal-title":"AIDS"},{"key":"10.1124\/jpet.124.002138_bib47","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11481-016-9699-0","article-title":"Effects of HIV and Methamphetamine on brain and behavior: evidence from human studies and animal models","volume":"11","author":"Soontornniyomkij","year":"2016","journal-title":"J\u00a0Neuroimmune Pharmacol"},{"key":"10.1124\/jpet.124.002138_bib48","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/jpet.120.266023","article-title":"[3H]Dopamine uptake through the dopamine and norepinephrine transporters is decreased in the prefrontal cortex of transgenic mice expressing HIV-1 transactivator of transcription protein","volume":"374","author":"Strauss","year":"2020","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1124\/jpet.124.002138_bib49","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1038\/s41598-017-03771-0","article-title":"Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter","volume":"7","author":"Sun","year":"2017","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.124.002138_bib50","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fcimb.2019.00362","article-title":"Microglial cells: the main HIV-1 reservoir in the brain","volume":"9","author":"Wallet","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1124\/jpet.124.002138_bib51","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/375497a0","article-title":"Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120","volume":"375","author":"Westendorp","year":"1995","journal-title":"Nature"},{"key":"10.1124\/jpet.124.002138_bib52","doi-asserted-by":"crossref","first-page":"11466","DOI":"10.1073\/pnas.97.21.11466","article-title":"Selective CXCR4 antagonism by Tat: implications for in\u00a0vivo expansion of coreceptor use by HIV-1","volume":"97","author":"Xiao","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/jpet.124.002138_bib53","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jneumeth.2011.03.001","article-title":"Demon voltammetry and analysis software: analysis of cocaine-induced alterations in dopamine signaling using multiple kinetic measures","volume":"202","author":"Yorgason","year":"2011","journal-title":"J\u00a0Neurosci Methods"},{"key":"10.1124\/jpet.124.002138_bib54","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.4155\/fmc-2016-0138","article-title":"Computational modeling of human dopamine transporter structures, mechanism and its interaction with HIV-1 transactivator of transcription","volume":"8","author":"Yuan","year":"2016","journal-title":"Future Med Chem"},{"key":"10.1124\/jpet.124.002138_bib55","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/syn.20949","article-title":"Recombinant human immunodeficiency virus-1 transactivator of transcription1\u201386 allosterically modulates dopamine transporter activity","volume":"65","author":"Zhu","year":"2011","journal-title":"Synapse"},{"key":"10.1124\/jpet.124.002138_bib56","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pharmthera.2017.10.007","article-title":"The role of human dopamine transporter in NeuroAIDS","volume":"183","author":"Zhu","year":"2018","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.124.002138_bib57","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0166-4328(03)00190-6","article-title":"Environmental enrichment enhances sensitization to GBR 12935-induced activity and decreases dopamine transporter function in the medial prefrontal cortex","volume":"148","author":"Zhu","year":"2004","journal-title":"Behav Brain Res"},{"key":"10.1124\/jpet.124.002138_bib58","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1124\/jpet.108.150144","article-title":"HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes","volume":"329","author":"Zhu","year":"2009","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1124\/jpet.124.002138_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109239","article-title":"SRI-32743, a novel allosteric modulator, attenuates HIV-1 Tat protein-induced inhibition of the dopamine transporter and alleviates the potentiation of cocaine reward in HIV-1 Tat transgenic mice","volume":"220","author":"Zhu","year":"2022","journal-title":"Neuropharmacology"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652400079X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652400079X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.124.002138","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T20:55:55Z","timestamp":1742244955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652400079X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S002235652400079X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.124.002138","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of pyrimidine structure-based compounds as allosteric ligands of the dopamine transporter as therapeutic agents for NeuroHIV","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.124.002138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100021"}}